Anavex Life Sciences
AVXL
#7563
Rank
ยฃ0.29 B
Marketcap
ยฃ3.30
Share price
-1.12%
Change (1 day)
-44.55%
Change (1 year)

Anavex Life Sciences (AVXL) - Total assets

Total assets on the balance sheet as of June 2025 : ยฃ76.89 Million

According to Anavex Life Sciences 's latest financial reports the company's total assets are ยฃ76.89 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Anavex Life Sciences - Total assets on balance sheet (from 2005 to 2025)

Total assets by year

Year Total assets Change
2024-09-30ยฃ0.10 B-19.93%
2023-09-30ยฃ0.12 B-7.77%
2022-09-30ยฃ0.13 B14.38%
2021-09-30ยฃ0.11 B348.7%
2020-09-30ยฃ26.74 M29.75%
2019-09-30ยฃ20.6 M2.54%
2018-09-30ยฃ20.09 M-3.28%
2017-09-30ยฃ20.78 M183.57%
2016-09-30ยฃ7.32 M-28.36%
2015-09-30ยฃ10.22 M125.53%
2014-09-30ยฃ4.53 M1765.9%
2013-09-30ยฃ0.24 M2879.85%
2012-09-30ยฃ0 M-93.73%
2011-09-30ยฃ0.13 M-38.05%
2010-09-30ยฃ0.2 M-18.33%
2009-09-30ยฃ0.25 M6200.48%
2008-09-30ยฃ0 M33252.38%
2007-09-30ยฃ0 M-99.82%
2006-09-30ยฃ0 M1103.2%
2005-09-30ยฃ0 M-96.45%
2004-09-30ยฃ0.01 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ1.10 B 1,341.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
ยฃ0.33 B 335.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ0.61 B 704.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
ยฃ2.79 M-96.36%๐Ÿ‡บ๐Ÿ‡ธ USA